Cap-dependent endonuclease-IN-14

• CAS Number:

  2740486-73-9

• UNSPSC Description:

  Cap-dependent endonuclease-IN-14 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-14 inhibits the replication of influenza virus. Cap-dependent endonuclease-IN-14 has the potential for the research of viral infections caused by influenza viruses (extracted from patent CN113620948A, compound 1-c)[1].

• Target Antigen:

  Influenza Virus

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/cap-dependent-endonuclease-in-14.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(OCOC1=C(C(C2(CC2)CN3C4C5=C(C6=C(C7=CC(F)=CC=C74)C=CS6)C=CC=C5)=O)N3C=CC1=O)OC

• Molecular Weight:

  558.58

• References & Citations:

  [1]Zhuqiang Lin, et al. cap-dependent endonuclease inhibitor. Patent CN113620948A.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported